| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.002 | 1 |